Skip to main content
OpenTrials
Completed

NCT Number: NCT02001350

Carotid Ultrasound Study

To use carotid ultrasound to screen 20-30 patients with longstanding or resistant hypertension for carotid atherosclerotic disease and bifurcation anatomy. This will establish a screening protocol for Cibiem's eventual endovascular carotid body modulation trial and will give insight into the prevalence and specific location of carotid plaque at the bifurcation in this patient population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Hypertension and Diabetology, Medical University of Gdansk

Gdansk, 80-952, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-75 years old
  • Uncontrolled hypertension on 3 or more medications or longstanding controlled hypertension on 4 or more medications.

Exclusion criteria

  • Previous stroke
  • Carotid endarterectomy or carotid stent procedure
  • >50% stenosis anywhere in carotid arteries

Treatment and study plan

Ultrasonography

Other

Primary outcomes

  1. Specific location of carotid plaque at the bifurcation

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Noblewell

Industry

Collaborators

  • Cibiem, Inc.

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Dec 4, 2013
Registry last updated
Oct 17, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.